Sri Vishnu Kiran Rompicharla

About Sri Vishnu Kiran Rompicharla

Sri Vishnu Kiran Rompicharla, With an exceptional h-index of 17 and a recent h-index of 16 (since 2020), a distinguished researcher at Birla Institute of Technology and Science, specializes in the field of Nanotechnology, cancer therapeutics, Ocular drug delivery, formulation, dendrimers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Next generation therapeutics for retinal neurodegenerative diseases

Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats

Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery

Nanofiber‐based glaucoma drainage implant improves surgical outcomes by modulating fibroblast behavior

Albumin-based lipoprotein nanoparticles for improved delivery and anticancer activity of curcumin for cancer treatment

Lipid and poly (ethylene glycol)-conjugated bi-functionalized chlorine e6 micelles for NIR-light induced photodynamic therapy

Chlorin e6 conjugated methoxy-poly (ethylene glycol)-poly (D, L-lactide) glutathione sensitive micelles for photodynamic therapy

A nanoscale, biocompatible and amphiphilic prodrug of cabazitaxel with improved anticancer efficacy against 3D spheroids of prostate cancer cells

Sri Vishnu Kiran Rompicharla Information

University

Position

Hyderabad

Citations(all)

822

Citations(since 2020)

736

Cited By

343

hIndex(all)

17

hIndex(since 2020)

16

i10Index(all)

23

i10Index(since 2020)

22

Email

University Profile Page

Google Scholar

Sri Vishnu Kiran Rompicharla Skills & Research Interests

Nanotechnology

cancer therapeutics

Ocular drug delivery

formulation

dendrimers

Top articles of Sri Vishnu Kiran Rompicharla

Next generation therapeutics for retinal neurodegenerative diseases

2024/3/1

Sri Vishnu Kiran Rompicharla
Sri Vishnu Kiran Rompicharla

H-Index: 11

Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats

Journal of Controlled Release

2023/10/1

Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery

Nature Communications

2023/5/2

Nanofiber‐based glaucoma drainage implant improves surgical outcomes by modulating fibroblast behavior

Bioengineering & Translational Medicine

2023/5

Albumin-based lipoprotein nanoparticles for improved delivery and anticancer activity of curcumin for cancer treatment

Nanomedicine

2020/10

Preeti Kumari
Preeti Kumari

H-Index: 12

Milan Paul
Milan Paul

H-Index: 1

Sri Vishnu Kiran Rompicharla
Sri Vishnu Kiran Rompicharla

H-Index: 11

Lipid and poly (ethylene glycol)-conjugated bi-functionalized chlorine e6 micelles for NIR-light induced photodynamic therapy

Photodiagnosis and Photodynamic Therapy

2020/3/1

Sri Vishnu Kiran Rompicharla
Sri Vishnu Kiran Rompicharla

H-Index: 11

Preeti Kumari
Preeti Kumari

H-Index: 12

Himanshu Bhatt
Himanshu Bhatt

H-Index: 8

Chlorin e6 conjugated methoxy-poly (ethylene glycol)-poly (D, L-lactide) glutathione sensitive micelles for photodynamic therapy

Pharmaceutical Research

2020/2

A nanoscale, biocompatible and amphiphilic prodrug of cabazitaxel with improved anticancer efficacy against 3D spheroids of prostate cancer cells

Materials Advances

2020

See List of Professors in Sri Vishnu Kiran Rompicharla University(Birla Institute of Technology and Science)

Co-Authors

academic-engine